Assessing medication discrepancies in pediatric patients: a cross-sectional feasibility study using the Medication

Berre Mercümek1,2, Muhammed Yunus Bektay3,4, Selcuk Uzuner5

  • 1Department of Clinical Pharmacy, Institute of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey. berre.mercumek@hotmail.com.

BMC Pediatrics
|November 4, 2025
PubMed

Insights

Medication reconciliation in pediatric transitions of care is improved by the Medication Discrepancy Taxonomy (MedTax). While feasible, MedTax needs refinement for pediatric complexities.

Area of Science:

  • Pediatric Pharmacology
  • Patient Safety
  • Health Informatics

Background:

  • Medication reconciliation (MedRec) is critical during transitions of care (ToC) to prevent errors.
  • Standardized tools for classifying medication discrepancies are inconsistently applied in pediatrics.
  • The Medication Discrepancy Taxonomy (MedTax) offers a potential solution for pediatric MedRec.

Purpose of the Study:

  • To assess the feasibility of the Medication Discrepancy Taxonomy (MedTax) for identifying and classifying medication discrepancies in pediatric patients during ToC.
  • To evaluate the effectiveness of MedTax in a real-world pediatric setting.
  • To identify areas for improvement in MedTax for pediatric application.

Main Methods:

  • Prospective cross-sectional study of pediatric patients hospitalized between August 2022 and February 2023.
  • Pharmacist-led MedRec during admissions and transfers.
  • Classification of discrepancies using MedTax for unintentional errors.

Main Results:

  • 105 pediatric patients included, with a mean of 8.35 medications per patient.
  • 518 medication discrepancies identified; 9.1% were unintentional.
  • MedTax classified all discrepancies, but 6.38% presented categorization challenges.

Conclusions:

  • The MedTax taxonomy is feasible for identifying and classifying pediatric medication discrepancies during ToC.
  • Refinement of MedTax is necessary to address pediatric-specific medication complexities.
  • Developing tailored tools is crucial for enhancing pediatric medication reconciliation.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
241
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
201
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
217
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
239
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
170
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
250